Researchers discovered a vulnerability in viral enzymes that could lead to novel treatments for diseases as diverse as COVID-19 and Ebola -- while also minimizing side effects and reducing the odds of ...
Epigenic, Immunocan have officially moved into Bayer Co.Lab, and AccurEdit Therapeutics will join early next month. Photo: Courtesy of Bayer Co.Lab Epigenic, Immunocan have officially moved into Bayer ...
The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic-;an effective antiviral that has since successfully treated millions.